Repligen Corporation (RGEN) vs Solventum Corporation (SOLV)
- Repligen Corporation RGEN 169.01 −5.16%
- Solventum Corporation SOLV 86.56 −3.12%
Repligen Corporation and Solventum Corporation are both Medical Instruments & Supplies companies. Solventum Corporation is the larger, with a market value of $14.8B against $10.8B — 1.4× the size. Repligen Corporation has negative trailing earnings, so its P/E is not meaningful; Solventum Corporation trades at 97.3×. Repligen Corporation grew revenue faster over the last twelve months: 13.8% against −2.84%. Solventum Corporation has the higher net margin (1.91% vs −1.47%) and the lower return on invested capital (0.00% vs 0.64%). Across the 18 metrics below, Repligen Corporation leads on 9 and Solventum Corporation on 9.
Valuation
Profitability
| Metric | RGEN | SOLV | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 53.46% | 0.00% | 53.60% |
| Operating margin | 2.26% | 0.00% | 1.97% |
| Net margin | (1.47%) | 1.91% | 0.00% |
| Free cash flow margin | 13.09% | 0.00% | 2.36% |
| Return on equity | (0.57%) | 3.19% | 0.00% |
| Return on assets | (0.40%) | 1.11% | 0.00% |
| Return on invested capital | 0.64% | 0.00% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack